New Approaches to Recurrent or Advanced Bladder Cancer

Dean F. Bajorin, MD, presents urothelial cancer, and reviews the expected survival rates for bladder cancer patients who receive first line treatment, and discusses new treatment options.

Back to Symposium Page »


February 20, 2021

Created by

Scripps CME Connection

Related Presenters

Dean Bajorin, MD

Dean Bajorin, MD

Medical Oncologist
Frederick R. Adler Senior Faculty Chair
Memorial Sloan Kettering Cancer Center

Dr. Dean Bajorin expertise is in the treatment of genitourinary tumors — particularly bladder and testicular cancers. As a member of Memorial Sloan Kettering’s Genitourinary Oncology faculty since 1986, he has diagnosed and treated thousands ...

View full profile